Indeed, but CRs and government grants have always been the sole income stream for RCE and, in my view, always will be. I agree with your available options assessment, however;
• raises more cash - this I see as their only viable strategy - as long as the shareholders are willing to keep putting their hands in their pockets
• is bought out - who would buy it at this stage? They have nothing proven of value, just the vague promise of 'new' technology
• enters into some form of arrangement with a large pharma - if, and when, they develop something that can make money - 'til then, no chance. Curative treatments hold little appeal for pharmaceuticals
Fortunately for Mr Graham, there are probably enough hopefuls and true believers to keep the gravy train chugging a while longer.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Indeed, but CRs and government grants have always been the sole...
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
65.0¢ |
Change
0.010(1.56%) |
Mkt cap ! $132.5M |
Open | High | Low | Value | Volume |
64.5¢ | 65.5¢ | 64.5¢ | $26.17K | 40.36K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 10615 | 65.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
65.5¢ | 6974 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 10615 | 0.650 |
1 | 13387 | 0.645 |
3 | 38930 | 0.630 |
1 | 4878 | 0.615 |
1 | 12099 | 0.610 |
Price($) | Vol. | No. |
---|---|---|
0.655 | 6974 | 1 |
0.660 | 70000 | 1 |
0.665 | 50000 | 1 |
0.670 | 50598 | 4 |
0.675 | 50000 | 1 |
Last trade - 16.10pm 13/05/2024 (20 minute delay) ? |
|
|||||
Last
65.0¢ |
  |
Change
0.010 ( 1.56 %) |
|||
Open | High | Low | Volume | ||
65.0¢ | 65.5¢ | 65.0¢ | 1745 | ||
Last updated 14.58pm 13/05/2024 ? |
Featured News
RCE (ASX) Chart |
The Watchlist
MGU
MAGNUM MINING AND EXPLORATION LIMITED
Neil Goodman, MD
Neil Goodman
MD
SPONSORED BY The Market Online